Page 3 - Time to DeLiver: Getting a Grip on HE report 2015

A message from
ELPA President,
Tatjana Reic

Hepatic encephalopathy (HE) is a debilitating condition
that affects up to 40% of patients across Europe who
suffer from advanced chronic liver disease.1 Despite the
severity of hepatic encephalopathy, it remains under-
diagnosed and under-treated, resulting in poor quality
of life for patients and their carers. To address this
challenge, the Time to DeLiver campaign was formed
with the aims of driving change in the perception of
hepatic encephalopathy among the public, healthcare
professionals, payers and policy makers, and to improve
the identification and management of this debilitating
condition. It is ELPA’s hope that this will ultimately benefit
both patients and carers, as well as healthcare systems
and policy makers.

The objectives of our campaign are to ensure the specific
inclusion of hepatic encephalopathy within public-facing
information, to improve the provision of quality care for
patients and to ensure the patient’s voice is heard on a
national and European level.

We hope you find the following report both interesting and
impactful, and you will commit to working with us as we
strive to develop strategies for overcoming the immense
burden hepatic encephalopathy places on patients, their
families and caregivers.

Yours sincerely,

Tatjana Reic

European Liver Patients Association (ELPA)
President

1